Cargando…
Detecting bad actors in value-based payment models
The U.S. federal government is spending billions of dollars to test a multitude of new approaches to pay for healthcare. Unintended consequences are a major consideration in the testing of these value-based payment (VBP) models. Since participation is generally voluntary, any unintended consequences...
Autores principales: | Lissenden, Brett, Lewis, Rebecca S., Giombi, Kristen C., Spain, Pamela C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237252/ https://www.ncbi.nlm.nih.gov/pubmed/34220292 http://dx.doi.org/10.1007/s10742-021-00253-9 |
Ejemplares similares
-
Leptin, Both Bad and Good Actor in Cancer
por: Jiménez-Cortegana, Carlos, et al.
Publicado: (2021) -
Fibrosis, the Bad Actor in Cardiorenal Syndromes: Mechanisms Involved
por: Delgado-Valero, Beatriz, et al.
Publicado: (2021) -
Biology must develop herd immunity against bad-actor molecules
por: Plemper, Richard K., et al.
Publicado: (2018) -
The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance
por: Duong, Minh Ngoc, et al.
Publicado: (2017) -
Moral contamination: Perceptions of good (but not bad) deeds depend on the ethical history of the actor
por: Protzko, John, et al.
Publicado: (2023)